Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization
about
Antibody Reactivity of B Cells in Lupus Patients with Increased Disease Activity and ARID3a Expression.Identification of peptide sequences as a measure of Anthrax vaccine stability during storage.Generation and Characterization of Human Monoclonal Antibodies Targeting Anthrax Protective Antigen following Vaccination with a Recombinant Protective Antigen Vaccine.Monoclonal antibodies and toxins--a perspective on function and isotype.A fully human monoclonal antibody with novel binding epitope and excellent neutralizing activity to multiple human IFN-α subtypes: A candidate therapy for systemic lupus erythematosus.Fully human monoclonal antibodies from antibody secreting cells after vaccination with Pneumovax®23 are serotype specific and facilitate opsonophagocytosis.Stochastic humoral immunity to Bacillus anthracis protective antigen: identification of anti-peptide IgG correlating with seroconversion to Lethal Toxin neutralizationAntigen nature and complexity influence human antibody light chain usage and specificity.Characterization of the native form of anthrax lethal factor for use in the toxin neutralization assay.Anthrax lethal toxin and the induction of CD4 T cell immunity.An overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.
P2860
Q33746233-87C65D50-76E4-4597-9EC0-6DDDF5DCAE9EQ34290957-8B52A2B3-0254-4347-8ED2-37A480CDD2E3Q35548062-BAF9DAC6-9236-4702-991D-9EEED2A7EA84Q36099489-98F5C634-3267-42EA-BA92-F9AF686C158AQ36214158-18669CF4-A9F3-45DD-979B-F136ADB3CC94Q36565432-A648D8FB-836C-485E-A11F-196F64F2AAC6Q36733960-DFB0CEAC-C622-4B6C-BC58-DD7F4D38CA0DQ36925942-40494C86-BDF0-4EC9-885F-290AA0DF5DF3Q36970210-D0EE560A-90E6-47E5-9ACF-283D607AF9F0Q38060730-4B7DC591-D423-4B1B-9AC0-2A0BF63ECFC5Q38446682-8CD36787-131E-4CBD-85E2-72477B7A1761
P2860
Human monoclonal antibodies generated following vaccination with AVA provide neutralization by blocking furin cleavage but not by preventing oligomerization
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Human monoclonal antibodies ge ...... by preventing oligomerization
@ast
Human monoclonal antibodies ge ...... by preventing oligomerization
@en
type
label
Human monoclonal antibodies ge ...... by preventing oligomerization
@ast
Human monoclonal antibodies ge ...... by preventing oligomerization
@en
prefLabel
Human monoclonal antibodies ge ...... by preventing oligomerization
@ast
Human monoclonal antibodies ge ...... by preventing oligomerization
@en
P2093
P2860
P1433
P1476
Human monoclonal antibodies ge ...... by preventing oligomerization
@en
P2093
A Darise Farris
Carla J Guthridge
Emily McKee
Jennifer J Muther
Kenneth Smith
Lori Garman
Nai-Ying Zheng
Patrick C Wilson
Sherry R Crowe
P2860
P304
P356
10.1016/J.VACCINE.2012.03.002
P407
P577
2012-03-14T00:00:00Z